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Abstract
Endothelial dysfunction is a precursor to atherosclerosis. Thus, the vascular health of an
individual can be assessed if endothelial dysfunction can be readily and unambiguously
quantified. A thermal-based approach using temperature and blood perfusion
measurements in conjunction with an arterial challenge has the potential to quantitatively
assess endothelial dysfunction. This report includes a detailed review of previous
attempts to characterize endothelial dysfunction and a preliminary evaluation of a
thermal-based approach that relies on temperature and perfusion measurements. Two
simple thermal models are used to contextualize results obtained from this technique.
Results reveal that this thermal-based method serves as a valid indicator of endothelial
assessment while at the same time reducing some of the mitigating factors of existing
approaches to identifying endothelial dysfunction. More testing must be performed in
order to optimize this thermal-based approach.
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1 Introduction
Atherosclerosis is a disease that affects many people, both the young and the old.
The disease is typically defined as hardening of the arteries. Dysfunction of the
endothelial cells that line the artery is seen as a pre-cursor to atherosclerosis. As a result,
a standard method for assessing endothelial dysfunction can lead to earlier assessment of
atherosclerosis. This report includes an investigation of previous and existing methods for
identifying endothelial dysfunction, such as flow-mediated dilation, brachial artery
ultrasound, strain gauge plethysmography, arterial tonometry, and assessment using
temperature. All of these existing approaches have certain limitations, such as operator-
dependent variability, inconsistent reproducibility, and complex data analysis methods. A
novel thermal-based approach that relies on evaluation of blood perfusion in addition to
temperature seems to offer the most promise, especially since this approach does not have
any of the aforementioned limitations.
Two simple models for the thermal interactions governing this thermal technique
have been proposed. One model describes the temperature profiles within unperfused
tissue when a constant temperature probe is placed in contact with the surface of the skin.
The second model describes the temperature profile for perfused tissue.
To explore the proposed theory of assessing endothelial function via temperature
and perfusion, a prototype of the thermal probe was built and tested. The thermal-based
approach relies on temperature and perfusion measurements in response to reactive
hyperemia. Therefore, an experiment was designed to measure temperature and perfusion
in response to reactive hyperemia induced b arterial occlusion. Experimental data was
evaluated to infer the status of a subject's vascular health. The results show that
measuring temperature and perfusion can prove to be a useful tool in identifying
endothelial dysfunction.
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2 Endothelial Dysfunction
2.1 Function of Endothelial Cells
Endothelial cells make up the lining of all blood vessels. They have a number of
functions, some of which include1' 2:
· Regulating vasoconstriction and vasodilation, and hence the control of blood
pressure
* Regulating vascular smooth muscle tone, local blood flow, vascular growth and
repair
* Balancing blood clotting and clot dissolution: maintaining a dynamic barrier
between tissue and the bloodstream
* Regulating immune function and inflammation, including inflammatory factors
that underly plaque formation and instability in occlusive (atherosclerotic)
vascular disease
* Controlling the passage of white blood cells, lipid particles, and foreign bodies
through the vascular wall, into and out of the blood stream
* Regulating tissue nourishment, ion transport, and electrolyte balance
Based on the list above, endothelial cells are responsible for a number of bodily
functions. Focusing on the relationship between endothelial cells and the vascular system,
a healthy endothelium plays a central role in cardiovascular control.3 For example, the
healthy endothelium dilates in response to an increase in blood flow.4 This vasodilation
can be induced by a blood pressure cuff squeezing the forearm to block off circulation,
followed by an immediate release to increase the blood flow.
There is also abundant evidence that the endothelium plays a crucial role in the
maintenance of vascular tone and structure. One of the major endothelium-derived
vasoactive mediators is nitric oxide (NO), an endogenous messenger molecule formed in
healthy vascular endothelium from the amino acid precursor L-arginine.5 Other
7
endothelium-derived substances are prostacyclin (PGI2) and C-type natriuretic peptide
(CNP). 6
2.2 Characteristics of Endothelial Dysfunction
Any deviation from the normal function of endothelial cells is classified as
endothelial dysfunction. For example, endothelial dysfunction is known to promote
abnormal vascular growth.6 In endothelium dysfunction the blood vessels' ability to
dilate is impaired and its ability to constrict is paradoxically increased; as such,
endothelium-derived dilating and constricting factors are reduced and increased,
respectively.7 Furthermore, impaired dilation is directly related to the ability of arterial
endothelial cells to produce and release the vasodilator nitric oxide; this impairment is
reflected in reduced production of NO. 8 Thus, abnormal vascular growth, impaired
dilation, and reduced levels of nitric oxide in the blood stream can all be regarded as
important markers of endothelial cell dysfunction. Additionally, there is also literature
which supports the notion that endothelial dysfunction is a reversible disorder.7
To understand the effect of nitric oxide on endothelial dysfunction, the biological
and biochemical processes must be explored. Decrease in the availability of nitric oxide
is associated with increased platelet adhesion, increased plasminogen activator inhibitor,
decreased plasminogen activator, increased tissue factor, decreased thrombomodulin, and
alterations in heparan sulfate proteoglycans. The consequences include a procoagulant
milieu and enhanced platelet thrombus formation. Furthermore, oxidized low-density
lipoprotein (LDL) activates inflammatory processes at the level of gene transcription by
up-regulation of nuclear factor kappa-B, expression of adhesion molecules, and
recruitment of monocytes and macrophages. Elevated serum levels of LDL cholesterol
overwhelm the antioxidant properties of the healthy endothelium and result in abnormal
endothelial metabolism of this lipid moiety. Oxidized LDL is capable of a wide range of
toxic effects and cell/vessel wall dysfunction, including impaired endothelium-dependent
dilation and paradoxical vasoconstriction. These dysfunctions are the result of direct
inactivation of nitric oxide by the excess production of free radicals, reduced
transcription of nitric oxide synthase messenger RNA (mRNA), and posttranscriptional
destabilization of mRNA.4
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Furthermore, endothelial damage also triggers platelets to adhere and aggregate at
the site of the damage, this enhances monocytes to enter the tunica intima, and
proliferation within the tunica-media junction of the artery. This effect causes the arterial
wall to herniate at this site. With increased monocyte invasion into arteries, and continual
herniation the lumen of the artery can become processively reduced. This combination of
biochemical and anatomical alterations contributes to oxidative stress and increased
vascular damage; the so-called precursors for atherogenic changes within arteries.9
2.2.1 Endothelial Dysfunction as a Precursor to Atherogenesis
and a Predictor of Vascular Disease
Studies have shown that endothelial dysfunction is significantly related to
atherogenesis.1 0 In fact, endothelial dysfunction is an early event in experimental studies
of atherogenesis, and it precedes the formation of plaques. Furthermore, oxidative stress
and increased vascular damage are also precursors to atherogenic changes within the
arteries.1 Therefore, endothelial dysfunction is the earliest measurable functional
abnormality of the vessel wall in atherogenesis. 3
Endothelial dysfunction reflects a vascular phenotype prone to atherogenesis and
may therefore serve as a marker of the inherent atherosclerotic risk in an individual. In
line with this hypothesis, dysfunction of either the coronary or peripheral vascular
endothelium is an independent predictor of cardiovascular events, providing valuable
prognostic information additional to that derived from conventional risk factor
assessment. 7Furthermore, in patients with diabetes mellitus, dysfunction of endothelial
cells has been postulated as an initial trigger of atherosclerosis and is believed to play a
pivotal role in the progression and/or development of vascular disease.6
2.2.2 Causes of Endothelial Dysfunction
One study stated that endothelial dysfunction is caused by various cardiovascular
risk factors, metabolic diseases, and systemic or local inflammation.5 Another study
corroborates this notion by stating, "Endothelial dysfunction is a consequence of the
harmful effects of the risk factors of atherosclerosis on the vessel wall and is more or less
important depending upon the number of risk factors, their intensity and their duration."3
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Endothelial dysfunction has been demonstrated in subjects with hypercholesterolemia,
diabetes, hypertension, in patients who smoke, and in patients with atherosclerotic
disease (coronary, peripheral arterial). 12 (cited in 3), 13 (cited in 3) Since endothelial dysfunction is
seen as a precursor to atherogenesis and other types of vascular disease, many of the risk
factors for these types of diseases are seen as risk factors for endothelial dysfunction.
These risk factors include: 14
· Elevated levels of oxidized serum cholesterol, triglycerides, fibrinogen,
homocysteine, or insulin
* High blood pressure
* Obesity
* Lifestyle factors such as physical inactivity and tobacco smoking
In addition to risk factors for atherosclerotic diseases, possible causes of damage to the
endothelium also include: free-radical reactions, chronic inflammation, and diabetes.' 4
Endothelial dysfunction also occurs in children. There is considerable evidence
that the pathogenesis of endothelial dysfunction and atherogenesis in childhood is related
to hypercholesterolemia and oxidation-sensitive mechanisms during early stages of
human development. These mechanisms can affect the subsequent fate of vascular lesions
in adult and elderly life.'5
From the biological perspective, dysfunction of endothelial cells causes loss of the
endothelium-derived substance NO, which induces an inflammatory response and recruits
oxidized LDL to activate this response. "Oxidized LDL is capable of a wide range of
toxic effects and cell/vessel wall dysfunctions that are characteristically and consistently
associated with the development of atherosclerosis. '"
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3 Atherosclerosis
Atherosclerosis comes from the Greek words athero, which means gruel or paste,
and sclerosis, which means hardness. It is typically defined as hardening or thickening of
an artery. A normal artery has many layers. The adventitia is the outermost wall, made up
of a fibrous material as well as smooth muscle cells. The media is the central layer of the
artery, consisting of multiple layers of smooth muscle cells. The intima is an innermost
layer of the artery and is made up of connective tissue, with endothelial cells acting as a
lining inside the arteries. It is on this innermost layer where deposits of fats (lipids),
cholesterol (lipoproteins), calcium, cellular waste products, and other substances build up
to cause atherosclerosis. This build-up is called plaque.
3.1 Progression of Atherosclerosis
Injury to the endothelial cells is the first step toward atherosclerosis.
Atherosclerosis begins when lipoproteins, or cholesterol, penetrate the endothelium and
accumulate in the intima. Gradually, these lipoproteins undergo a series of chemical
changes, one of which being oxidation. Oxidation occurs when excess amounts of
unstable oxygen-free radicals are available to interact with and alter nearby molecules.
The oxidized lipoproteins release a number of toxins into the arterial wall in response to
oxidation and the area becomes inflamed.16 The immune system is then signaled to
release macrophages at the site of inflammation. This initiates a process called the
inflammatory response. Macrophages literally "eat" the oxidized cholesterol leaving
behind foamy cells that attach to the artery's smooth muscle cells. The foamy cells then
build up within the artery. After the immune system senses the foamy cells, it releases
other factors called cytokines, which attract more macrophages and perpetuate the whole
cycle. This cycle usually repeats itself forming atherosclerotic lesions. 17
The next step involves the recruitment of white blood cells, or leukocytes, to the
site of the injury. These cells also migrate into the arterial wall, and over time, the site
begins to accumulate more white blood cells and blood lipids, including various forms of
cholesterol (LDL, VLDL and triglycerides). Eventually, a plaque forms. 16
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As fatty material accumulates, some of the plaque formations acquire a relatively
thick covering. These are considered to be stable plaques and are a primary cause of
narrowed arteries. Other plaques have a thinner, more volatile coating. These are called
unstable plaques, because the coating can be stripped off, releasing small fatty particles
into the bloodstream and causing plaque rupture. 16
The site of the plaque rupture attracts blood platelets. When platelets find an
injury, they rapidly gather and initiate a cascade of events that results in a blood clot. If
this happens inside the coronary artery, the resulting blood clot can cause a heart attack.
If it blocks a blood vessel that feeds the brain, it causes a stroke. And if it reduces blood
supply to the arms or legs, it can cause difficulty walking and eventually gangrene.18
In short, atherosclerosis involves the slow buildup of deposits of fatty substances,
cholesterol, body cellular waste products, leukocytes, and fibrin on the inside lining of an
artery. The plaque that results can partially or totally block the flow of blood through the
artery. If the plaque ruptures, this can lead to the formation of a blood clot on the surface
of the plaque. The occurrence of either event can block the entire artery and cause a heart
attack, a stroke, or even gangrene.
3.2 Mechanical Interactions during Atherosclerosis
From a mechanical point of view, the lesions of atherosclerosis do not occur in a
random fashion. Hemodynamic factors interact with the activated vascular endothelium.
Fluid shear stresses generated by blood flow influence the phenotype of the endothelial
cells by modulation of gene expression and regulation of the activity of flow-sensitive
proteins. Atherosclerotic plaques characteristically occur in regions of branching, marked
curvatures, and geometric irregularities; it is in these regions where blood velocity
undergoes sudden changes in magnitude and direction of flow. The decreased shear stress
and turbulence has the potential to promote atherogenesis at these locations. Primary sites
for these distinct geometric changes are the coronary arteries, the major branches of the
thoracic and abdominal aorta, and the large conduit vessels of the lower extremities.4
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3.3 Risk Factors for Atherosclerosis
There are certain risk factors for atherosclerosis, some of which include:
· Excess amounts of oxygen free radicals. Oxygen-free radicals are usually released
as part of normal bodily processes, but environmental toxins, such as viruses or
smoking, can hinder the body from releasing them and produce excess amounts.17
* High concentrations of LDL. It has been shown that the greater the concentration
of LDL, the greater the risk of developing atherosclerosis.9
* Artery size. Atherosclerosis usually affects large and medium-sized arteries.'8
* Age. Fatty deposits of plaque usually develop over many years.17 Some hardening
of arteries often occurs when people grow older.18
* High blood cholesterol, overweight, little exercise, smoking'9
3.4 Atherosclerosis and Aging
It was once thought that atherosclerosis affected only middle- aged and elderly
people. Since then, researchers have learned that atherosclerosis typically begins in
childhood with fatty streaks that develop on the interior wall of an artery. These streaks
lay the foundation for a buildup of plaque and also cause the artery to gradually lose its
elasticity. This is compounded by the fact that the arteries naturally become less flexible
with age. Although the process may take many years, it is greatly accelerated by the
presence of saturated fat and cholesterol in the bloodstream. 16 Therefore, atherosclerosis
progresses rapidly in some people and signs are prevalent even in their third decade. 18
3.5 Systemic Nature of Atherosclerosis
Atherosclerosis can affect the arteries of the brain, heart, kidneys, arms and legs.20
Typically, atherosclerosis affects medium and large sized arteries. It most frequently
affects the aorta (the largest blood vessel in the body), the coronary arteries, the cerebral
arteries, and sometimes arteries in the legs and abdomen.17 As mentioned earlier, a
blocked coronary artery can cause a heart attack, and blocked carotid arteries in the neck
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or cerebral arteries in the brain can lead to a stroke. And, inadequate blood flow to the
lower extremities can cause peripheral arterial disease - a condition that can lead to poor
circulation, leg pain with walking (claudication), non-healing leg ulcers, and gangrene. 16
3.6 Testing for Atherosclerosis
Atherosclerosis may not be diagnosed until symptoms develop. Prior to
complications, atherosclerosis may be noted by the presence of a "bruit" (a whooshing or
blowing sound heard over the artery with a stethoscope). The affected area may have a
decreased pulse. Tests that indicate atherosclerosis (or complications) include:21
· An abnormal difference between the blood pressure of the ankle and arm
(ankle/brachial index, or ABI)
* Doppler study of the affected area
* Ultrasonic Duplex scanning
* CT scan of the affected area
* Magnetic resonance arteriography (MRA)
* Arteriography of the affected area
* Intravascular ultrasound (IVUS) of the affected vessels
* Cardiac stress testing
Atherosclerosis involving the heart may also be diagnosed through:16
· Electrocardiogram, or EKG
* Exercise stress test
* Nuclear stress test, a form of stress testing that involves the injection of a
radionucleotide contrast agent such as thallium, myoview, sestamibi
* Ultrafast computed tomography, or ultrafast CT
* Coronary Angiogram (more invasive)
14
Additionally, researchers are studying new tools to help find cardiovascular
disease in earlier stages, before symptoms appear. For example, the National Heart,
Lung, and Blood Institute is sponsoring a ten-year study called the Multi-Ethnic Study of
Atherosclerosis (MESA). The MESA study will help show which risk factors are the best
predictors of future heart disease in men and women and in certain ethnic groups. For
now, individuals should suspect that they are at a high risk for atherosclerosis if they have
high blood cholesterol, are overweight and get little exercise, smoke, or have any other
risk factors.1 9
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4 Identifying Atherosclerosis via Measurement and
Assessment of Endothelial Dysfunction
4.1 Implications of the Connection between Endothelial
Dysfunction and Atherosclerosis
Given the relationship between endothelial dysfunction and atherosclerosis, it is
likely that the status of endothelial function may reflect the propensity of an individual to
develop atherosclerotic disease, and thus, the presence of endothelial dysfunction may
serve as a marker of an unfavorable cardiovascular prognosis.7 For example, the brachial
arterial dilator response to increased blood flow during reactive hyperemia has been
shown to be caused mainly by an endothelial release of NO, to correlate significantly
with endothelial function, as well as with the extent and severity of atherosclerosis. 3
Additionally, endothelial dysfunction induces disruption of the balance between
vasoconstrictive factors and vasodilatory factors secreted from endothelial cells. Among
these factors, NO and angiotensin II are especially important factors, and have been
shown to exert various direct effects on the endothelial functions that are closely related
to the pathogenesis of atherosclerosis. Endothelial dysfunction induces decreased NO
bioactivity and increased angiotensin II expression, which increases oxidative stress and
expression of adhesion molecules, cytokines, and chemokines. These conditions mediate
inflammation, proliferation, and thrombogenesis in vessel wall and promote
atherosclerotic lesions.2 2
Therefore, endothelial dysfunction is a key variable in the pathogenesis of
atherosclerosis and its complications. With the important role of endothelial dysfunction
for the development and progression of atherosclerosis, it seems attractive to consider
endothelial dysfunction, aside from the treatment of established cardiovascular risk
factors, as a primary therapeutic target in the prevention of atherosclerotic disease.7
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Less-invasive or noninvasive techniques for the assessment of endothelial
function include: strain-gauge forearm plethysmography in conjunction with intra-arterial
infusion of endothelium-dependent vasodilators, such as methacholine or acetylcholine; a
high-resolution external vascular ultrasound to measure flow-mediated endothelium-
dependent dilation (FMD) of the brachial artery during reactive hyperemia; brachial
artery ultrasound; arterial tonometry; and temperature assessment of the certain locations
on the hand before, during, and after reactive hyperemia. These techniques are based on
the fact that endothelial dysfunction is not confined to the coronary arteries but rather
represents a systemic disorder that also affects peripheral vascular beds, including both
conduit arteries and small resistance vessels in the extremities.7
4.2 Flow Mediated Dilation
Flow Mediated Dilation (FMD) is a technique that was developed in the 1990s; it
uses ultrasound images to asses vasomotor dilation due to a stimulus, which is usually an
inflated cuff placed around the bicep area. An image of the brachial artery is taken before
and after the stimulus is applied to determine percent dilation. Essentially, FMD
measures the ability of an artery to relax in response to the increase in blood flow, or
blood velocity, caused by the stimulus. The technique also provokes the release of nitric
oxide, resulting in vasodilation, which can be regarded as an index of vasomotor
function. 23 ,24 ,2 5,2 6
Looking at the technique from a biological perspective, the endothelial cell
membrane contains specialized ion channels, such as calcium-activated potassium
channels, that open in response to shear stress. Although FMD is known to involve these
specialized ion-channels within the endothelial cells, the precise mechanisms for the
acute detection of shear forces and subsequent signal transduction to modulate vasomotor
tone are not fully understood. However, the effect of potassium channel opening is to
hyperpolarize the endothelial cell, increasing the driving force for calcium entry (there
are no voltage-gated calcium channels in endothelial cells). Calcium activates an enzyme,
endothelial nitric oxide synthase (eNOS), and the subsequent generation of NO appears
to account for FMD. Furthermore, endothelial denudation or treatment with a nitric oxide
synthase (NOS) inhibitor abolishes FMD in a variety of arterial vessels.26
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4.2.1 FMD Subject Preparation
The subject preparation for this technique must adhere to a specific protocol. This
protocol takes into account the fact that numerous factors affect flow-mediated vascular
reactivity, such as temperature, food, drugs and sympathetic stimuli. The protocol is as
follows:2 6
· Subjects should fast for at least 8 to 12 h before the study.
· Subjects should be studied in a quiet, temperature-controlled room.
* All vasoactive medications should be withheld for at least four half-lives, if
possible.
· Subjects should not exercise.
· Subjects should not ingest substances that might affect FMD such as caffeine,
high-fat foods and vitamin C or use tobacco for at least 4 to 6 h before the
study.
· The investigator should be cognizant of the phase of the subject's menstrual
cycle, as it too may affect FMD.
All of these confounding factors must be considered in preparing a subject in studies that
seek to determine the impact of a single intervention. For observational cohort studies,
data must be collected on those factors known to affect the measurement of FMD, and
analysis should address their impact.
4.2.2 Measurement Methods for FMD
4.2.2.1 Equipment
Certain pieces of equipment must be available to evaluate FMD. Ultrasound
systems must be equipped with vascular software for two-dimensional (2D) imaging,
color and spectral Doppler, an internal electrocardiogram (ECG) monitor and a high-
frequency vascular transducer. A linear array transducer with a minimum frequency of 7
MHz, attached to a high-quality mainframe ultrasound system, is used to acquire images
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with sufficient resolution for subsequent analysis. Image resolution is enhanced with
broadband (multiple-frequency: 7 to 12 MHz) linear array transducers. Timing of each
image frame with respect to the cardiac cycle is determined with simultaneous ECG
recording on the ultrasound system video monitor.26
4.2.2.2 Image Acquisition and Assessment 6
The image acquired with this equipment should be standard for all test subjects. In
order to ensure that this is the case, the subject is positioned supine with the arm in a
comfortable position for imaging the brachial artery. The brachial artery is imaged above
the antecubital fossa in the longitudinal plane. A segment with clear anterior and
posterior intimal interfaces between the lumen and vessel wall is selected for continuous
2D grayscale imaging. Currently, cross-sectional imaging of the brachial artery cannot be
used to determine maximum diameter or area of the lumen because of inadequate image
definition of the lateral walls. Also, skew artifacts from cross-sectional imaging limit
accurate diameter determination. In addition to 2D grayscale imaging, both M mode and
A mode (wall tracking) can be used to continuously measure the diameter, yet these
techniques may be more subject to error owing to tracking drift. No direct comparison
has been made of diameter determinations from continuous recording using grayscale
images versus wall tracking. During image acquisition, anatomic landmarks such as veins
and fascial planes are noted to help maintain the same image of the artery throughout the
study. A stereotactic probe-holding device can be helpful. Accurate analysis of brachial
artery reactivity is highly dependent on the quality of ultrasound images.
Several studies have suggested that the maximal increase in diameter occurs
approximately 60 s after release of the occlusive cuff, or 45 to 60 s after peak reactive
hyperemic blood flow. The increase in diameter at this time is prevented by the NOS
inhibitor NG-monomethyl-l.-arginine, indicating that it is an endothelium-dependent
process mediated by NO. Other measures of vasodilator response include time to
maximum response, duration of the vasodilator response and the area under the dilation
curve.
Timing of the measurement during the cardiac cycle is also done in a precise
manner. Brachial artery diameter should be measured at the same time in the cardiac
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cycle, optimally achieved using ECG gating during image acquisition. The onset of the
R-wave is used to identify end diastole, and the peak of the T-wave reproducibly
identifies end systole. Peak systolic diameter is larger than end systolic diameter, because
the vessel expands during systole to accommodate the increase in pressure and volume
generated by left ventricular contraction. The magnitude of systolic expansion is affected
by the vessel compliance, and it may be reduced by factors such as aging and
hypertension (possibly by reduced bioavailability of NO). Thus, functional characteristics
of the brachial artery may obfuscate the measurement of FMD if diameter is measured
during end systole; however, this concern has not been tested in a rigorous trial.
Although it may seem simple, ultrasonographic assessment of brachial artery
reactivity is technically challenging and has a significant learning curve. Ideally, an
individual trained in the principles and technical aspects of 2D and Doppler
ultrasonography would perform the technique. The learning curve typically requires
several months and depends both on the technical skill of the individual and the
frequency with which the technique is performed. Optimal training in the technique
requires hands-on training by an experienced individual who can demonstrate the pitfalls
and ultrasound artifacts and who can delineate manual techniques and optimal
ultrasonography system parameters.
4.2.2.3 FMD Data Analysis2 6
Several approaches exist to describe the differences in any two sets of
measurement results. One is the correlation coefficient, which is derived from data that
represent the entire range of measurements anticipated in the setting in which the
technique will be employed. A second metric is simply the mean and range of differences
between the measures, which gives an intuitive understanding of the lower limits of
differences that can meaningfully be ascribed to variation between subjects or secondary
to intervention. The third metric, the coefficient of variation, is intended to communicate
the size of the variance of a measure relative to the mean value of what is being
measured. Because FMD is a percentage-ratio measure, small differences between
observers appear very large.
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There is no single ideal measurement to assess reproducibility of this technique. A
scatterplot showing results obtained at time one and time two along with the line of
identity, accompanied by the results of the three metrics described in the previous text, is
likely the most complete way to describe reproducibility of FMD of the brachial artery.
Rigorous attention to protocol standardization, training and ongoing quality improvement
is critical to generating valid, reproducible data.
4.2.3 Studies Involving FMD
This section contains abstracts of three specific studies involving FMD: (1) Local
Shear Stress and Brachial Artery Flow-Mediated Dilation; (2) Variability of Flow-
Mediated Dilation Measurements with Repetitive Reactive Hyperemia; and (3)
Noninvasive Assessment of Vascular Function in the Posterior Tibial Artery of Healthy
Humans.
Local Shear Stress and Brachial Artery Flow-Mediated Dilation:
The first study recognizes that flow-mediated dilation is a homeostatic response
to short-term increases in local shear stress. It focuses on the effect of risk factors on
evoked shear stress caused by the stimulus for dilation. The risk factors included: age,
sex, mean arterial pressure, pulse pressure, heart rate, body mass index, lipid medication
use, and hormone replacement therapy. These risk factors were correlated with percent
dilation in two separate models: one excluded the effect of shear stress and the other
included it. The study agrees with the notion that evoked hyperemic shear stress is a
major correlate of brachial artery flow-mediated dilation, but concludes that the
associations between many risk factors and FMD may be a result of a reduced stimulus
for dilation, rather than a result of impaired local conduit artery response during
hyperemia. 23
Noninvasive Assessment of Vascular Function in the Posterior Tibial Artery of Healthy
Humans:
The second study sought to assess FMD in the lower legs of humans. Six healthy
subjects (27 ±t 6 yrs) were tested. Doppler ultrasound images of the posterior tibial artery
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were taken before, during, and after 5 minutes of proximal cuff occlusion. FMD was
measured as the percent increase in diameter after cuff release. Vascular tone was
calculated using the resting diameter as a percentage of the vessel's vasoactive range.
Minimum diameter occurred during ischemia and maximal diameter occurred following
reactive hyperemia with local heating. The lower leg was heated with 10 minutes of
immersion in 44°C water. Mean diameters at rest, cuff, and during release were 0.267 ±
0.062, 0.162 ± 0.036, 0.302 ± 0.058 cm, respectively. FMD was 13.5 ± 6.6 % and
vascular tone was 29 ± 16.3%. The researchers also found that retesting on a second day
produced mean diameter values within 8% of the first day. Larger resting diameter
(decreased tone) correlated with decreased FMD (r2 = 0.73). This study concluded that
FMD and vascular tone can be measured in the posterior tibial artery, and this is a
potentially powerful tool to non-invasively measure vascular health in the lower legs of
people at risk for vascular disease.25
Variability of Flow-Mediated Dilation Measurements with Repetitive Reactive
Hyperemia:
The third study set out to examine the effect of repetitive reactive hyperemia on
brachial artery FMD as well as to determine whether brachial artery FMD is stable during
a 2-h morning period. FMD was investigated in 20 apparently healthy college students on
three randomized treatment days every 30 min, 60 min, and 120 min throughout a 2-h
morning period (08AM to 10AM). The study found that repetitive reactive hyperemia
over a 2-h period has no effect on FMD measurements in apparently healthy college
students. There was also a stable FMD response throughout the 2-h morning period.24
4.2.4 Limitations of FMD
The development of FMD as a non-invasive measurement of brachial artery
reactivity has increased the ability to identify and detect cardiovascular disease before the
symptoms arise.24 Despite its widespread use as a research tool and the development of
guidelines to standardize its use,26 protocols for assessing FMD of the brachial artery still
vary among different laboratories and are operator dependent. This decreases the
feasibility of this noninvasive technique as a valuable screening tool for endothelial
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dysfunction in clinical practice. 7 Furthermore, the smaller baseline artery diameter seen
in women, leading to an increased and possible false-negative FMD, has also questioned
the reliability and sensitivity of this measurement; although, it is accepted that FMD
varies among subjects. An additional limitation to this technique is the burdensome
necessity of performing multiple post intervention measurements of flow-mediated
dilation in order to capture the response of a single acute intervention. There are also
interpretive limitations to this technique.26 Thus, there is growing interest in developing a
noninvasive, reliable method to assess endothelial function.
4.3 Brachial Artery Ultrasound
Brachial artery ultrasound is also used widely as a noninvasive measure of
endothelial cell function. In this method, the forearm blood flow is occluded for 5
minutes using a blood pressure cuff maintained at a standard pressure. When the pressure
is released, reactive hyperemia occurs. This results in shear stress-induced NO release
and subsequent vasodilatation (flow-mediated vasodilatation). This technique has the
advantage of being noninvasive and can readily identify populations with attenuated
endothelial function. The major limitations of this technique are the need for
ultrasonographic expertise and a significant day-to-day variability (about 25%) due to
biological circadian rhythms. Nonetheless, at present, this approach is widely used to
assess vasomotion function.27
4.4 Strain Gauge Plethsmography
Strain gauge plethysmography is a standardized technique to measure flow and
vascular resistance by using a special transducer placed on the forearm and use of two
inflated blood pressure cuffs proximal and distal to the site for the temporary occlusion of
either venous or arterial flow. This technique also has been used to assess endothelial
dysfunction by measurements of blood flow volume and rate of flow into the forearm.28
Strain gauges employed in plethysmography for determination of limb blood flow tend to
counter the expansion of the limb during venous occlusion. Traditionally a mechanical
calibration is performed in situ to compensate for tissue compressibility.2 9
23
Blood flow in the human forearm or calf can be monitored non-invasively by
venous occlusion plethysmography with an optional PowerLab system. Venous occlusion
plethysmography involves tying a strain gauge around the limb. The strain gauge could
be a stretchable tube containing a liquid metal such as mercury or an indium-gallium
alloy. Changes in limb circumference alter the cross-sectional area of the tube and hence
the electrical resistance of the liquid metal. 30 This method samples the swelling at one
point in the length of the limb, as opposed to measuring the possibly uneven swelling all
down the limb. Hence the absolute results should be treated with caution, but comparison
between treatments and subjects is legitimate and shows reasonable consistency in
practice.30 Changes in limb circumference can be monitored by a suitable meter, which
can output an analog voltage signal direct to a PowerLab system. A sample strain gauge
is illustrated in Figure 4-1.
Figure 4-1: Hokanson strain gauge. This strain gauge is used to take quantitative bloodflow
measurements noninvasively. It uses a four-wire construction to eliminate errors caused by lead
resistance. 29
Forearm blood flow is measured by stopping the flow out of the limb at an instant
while not changing the rate of arterial inflow. This is done by temporarily occluding the
venous occlusion cuff placed just above the elbow and inflated to about 60 mmHg. This
pressure is sufficient to shut the veins but not the arteries. The slight swelling of the distal
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portion of the limb due to continued arterial inflow is then measured. As blood flows into
the limb, it cuases the limb to swell and the rate of swelling is a measure of the arterial
flow rate at that instant. The assumption is made that flow is similar throughout the limb
so the volume flow rate is equal throughout the measurement volume. Flow in the hand is
quite variable so it is usually stopped during the test by inflating a wrist cuff above
systolic pressure.29 In theory, the limb swelling will plateau after a while as the venous
pressure rises sufficiently to cause renewed venous outflow past the obstruction.
However, the initial rate of swelling should represent arterial inflow under relatively
normal conditions. 3 1
Since blood flow varies continuously in response to various physiological effects,
such as thermoregulation, psychological state, and exercise (coming up the stairs to the
lab), there isn't a unique value for forearm blood flow. A rested subject in a stable
environment is likely to give the most consistent results, but there is still likely to be
some more-or-less cyclical variation over periods of minutes to tens of minutes.31
4.4.1 Measurement Methods for SGP
4.4.1.1 SGP Basic Equipment
To make blood flow measurements with the SPG technique, the basic equipment
includes: a strain gauge, output recording device, and an occluding cuff. The strain needs
to be selected according to the limb circumference. Along with the strain guage, there
needs to be a system that provides easy recording and analysis of the SPG signal, or
plethysmograph output. The occluding cuff is used to provoke a hyperemic response.
Either the upper arm cuff can be used alone or both the upper arm and the wrist can be
used as sites for the occlusion of blood flow. Rapid inflation of these cuffs is desirable in
order to measure the initial slope of the inflow curve, and an automatic cuff inflator is
often recommended for this task.3'
4.4.1.2 SGP Technique
The rested subject is made comfortable with the arm supported by foam blocks or
slings at the wrist and elbow. The cuff is fitted, but not yet inflated. Once the cuff is
inflated, initial flow is measured by determining the initial slope of the volume curve
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after any cuff artifact which might exist, where the cuff artifact is a rapid rise of the curve
immediately after inflation of the venous occlusion cuff.31 Flow rates are commonly
measured in the cc's of flow per 100 cc's of tissue. This type of normalized measurement
makes it possible to compare flow rates regardless of the subject's size.29
4.4.1.3 SGP Data Analysis
There are two methods by which data can be anaylyzed: manually and
electronically. To manually determine blood flow, a line is drawn tangent to the first
pulses after the cuff artifact. Drawing the line requires some judgement, but with practice,
consistent results are possible. To determine the slope of the line, the change in volume
per unit time must be calculated. Examples of manual results are shown in Figure 4-2.
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Figure 4-2: Manual data analysis of a strain gauge plethsmograph. This chart was recorded from a
TL400 Totalab strain gauge plethysmograph. The tangent line is then drawn and the time for this
line to cross the chart is 17.8 seconds. The volume change across the chart is 0.8% and the flow rate
is therefore 2.70 %/min.3 '
This measurement can also be performed with the aid of a computer program. A
gauged is selected and fitted to the limb at a standardized fraction of the forearm length.
The system is then electronically calibrated to give exact % stretch for that particular
gauge and initial limb circumference. (The calibration method depends on the electronics
used. The output is actually % increase in limb cross-sectional area, which is twice the %
circumference increase.) The cuff is inflated to a standard pressure (usually about 60 mm
Hg) while the SPG signal is recorded. If required, this step is repeated a number of times.
On the recording, the initial slope is measured and noted. On a Biopac system with the
AcqKnowledge software, this consists of dragging a cursor over the relevant period of the
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waveform and transferring the resulting least-squares slope to a journal with a single
keystroke.29 Figure 4-3 shows a snapshot window of a typical result:
Figure 4-3: Electronic data analysis of a strain gauge plethsmograph using the AcqKnowledge
software with a Biopac system.
With a calibrated electronic system, the result will be in %/o/s. Based on an assumption of
uniform swelling along the limb, the units of the result can be interpreted as mls blood /
100 ml tissue / second. A typical result for forearm flow is of the order of 0.1 ml/100 ml/s
(or 5 ml/100 ml/minute).2 9
4.5 Arterial Tonometry
Arterial tonometry was first developed in 1963 by G.L. Pressman and P.M.
Newgard. Arterial tonometry allows non-invasive and continuous registration of the
arterial pressure waveform, by applanating, or flattening, a superficial artery supported by
bone with an external transducer. This technique provides the clinician with numeric
values for systolic, mean, and diastolic pressures, and a numeric value for pulse
rate.32 33'34 The sensor used for tonometry is placed on the wrist over the radial artery as
shown in the Figure 4-4.
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Figure 4-4: Tonometry sensor device32
The sensor contains piezoelectric pressure transducers separated by 0.2 mm. A
pneumatic pump and bellows press the transducer array against the skin and tissue above
the artery. A schematic of this description is shown in Figure 4-5.
Figure 4-5: Schematic of how the tonometry sensor works32
The pressure recorded when the transducer is pressed against the skin is called the
hold down pressure (HDP). To determine optimal HDP, the monitor searches through a
range of pressure values until it measures a signal indicating that the artery is of the form
shown in the figure below. When the artery is partially flattened, a graph, called a
tonogram, can be plotted to show sensor pulse amplitude versus transducer number. The
individual sensor elements whose pulse amplitudes are near the maximum pulse
amplitude are calibrated to the systolic and diastolic values obtained in the oscillometric
cuff measurement.32 The accuracy of this method depends on the performance of both the
piezoelectric crystal array and the oscillometric cuff.33 A schematic of the plot is shown
in Figure 4-6.
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Figure 4-6: Schematic of the tonogram produced with variations in hold-down pressure32
4.5.1 Advancements in Tonometry
Although G.L. Pressman and P.M. Newgard built the first arterial tonometer in
1963, accuracy remained poor until the onset of silicon technology and the development
of new sensor production techniques. G.M. Drzewiecki et al. published a second, more
elaborate theoretical model for tonometer positioning in 1983. A few years thereafter, the
first modem tonometers were commercialized. Although the problems of sensor
positioning, motion artefacts and calibration still exist, the tonometer has proven its
usefulness in arterial compliance and hypertension studies. Attention should now go to
analysis of the arterial pressure waveforms, and the combination with other signals (e.g.
flow wave morphology) to allow a complete non-invasive haemodynamical description
of the heart and the arterial tree.34
4.5.2 Studies Using Arterial Tonometry
This section contains abstracts of three studies that use arterial tonometry: (1)
Comparison of Arterial Tonometry with Radial Artery Catheter Measurements of Blood
Pressure in Anesthetized Patients; (2) Peripheral Arterial Tonometry: A Diagnostic
Method for Detection of Myocardial Ischemia Induced during Mental Stress Tests: A
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Pilot Study; and (3) Estimation of Central Aortic Pressure Waveform by Mathematical
Transformation of Radial Tonometry Pressure.
Comparison of Arterial Tonometry with Radial Artery Catheter Measurements of Blood
Pressure in Anesthetized Patients:
The first study seeks to evaluate the overall performance of arterial tonometry in terms of
the performance of the piezoelectric crystal array and the oscillometric cuff by comparing
it with simultaneous recording of blood pressure from an intraarterial catheter. Seventeen
adult patients were studied during general anesthesia. Blood pressure was measured with
an intraarterial catheter and with an arterial tonometry system. Analog pressure
waveforms were sampled at 100 Hz. Blood pressure measurements obtained by
oscillometry were recorded by computer. Comparisons of mean blood pressure on a beat-
by-beat basis were made with and without correction for the calibration error introduced
by oscillometry. The difference between pairs of blood pressure determined by arterial
tonometry and intraarterial measurement was 1.3 +/- 9.4 mmHg (mean +/- SD, bias +/-
precision) with 88,158 pairs of measurements. The difference between blood pressure
determined by oscillometry and intraarterial measurement was 2.4 +/- 7.5 mmHg (mean
+/- SD) with 401 comparisons. After correcting for calibration error, the difference
between the tonometry measurements and intraarterial measurements was -1.0 +/- 5.6
mmHg. Continuous episodes of discrepancy from intraarterial measurements in excess of
10 mmHg and lasting 5-60 s occurred 4.6 +/- 0.8 times per hour with tonometry and 12.6
+/- 1.4 times per hour with oscillometry. The study concluded that discrepancies in blood
pressure readings by arterial tonometry versus intraarterial measurement result from both
the piezoelectric crystal array and the oscillometry used for calibration. Accuracy for
individual measurement is inferior to oscillometry alone. Additionally, the ability to
detect significant changes of blood pressure more rapidly than with oscillometry alone is
limited by the accuracy of the piezoelectric crystal component but is enhanced by the
reduced interval between measurements.33
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Peripheral Arterial Tonometry: A Diagnostic Method for Detection of Myocardial
Ischemia Induced during Mental Stress Tests, A Pilot Study:
The second study was undertaken to test the diagnostic capability of peripheral arterial
tonometry (PAT) to detect peripheral arterial vasomotor changes. This study is based on
the assumption that arterial tonometry is a valid indicator of vasomotor changes. The
researchers monitored pulsatile finger blood volume changes using a unique finger
plethysmograph, PAT designed to detect peripheral arterial vasomotor changes. Since it
has been shown that myocardial ischemia induced during mental stress tests is
specifically associated with peripheral arterial vasoconstriction, equilibrium radionuclide
angiography (ERNA) performed simultaneously with PAT in 18 male patients. PAT and
ERNA were performed when the patients were at rest as well as during a mental
arithmetic stress test with harassment. All patients had previously diagnosed coronary
disease and positive exercise tests. Peripheral arterial tonometry tracings were considered
abnormal when the pulse wave amplitude decreased by >20% from baseline. (Myocardial
ischemia was diagnosed by ERNA when global ejection fraction fell >8% during mental
stress or when new / worsened focal wall motion abnormalities occurred.) There were
only 16 usable studies out of the 18 subjects tested. Both ERNA and PAT were abnormal
in 8 patients. The tests were negative by both methods in 6 patients, and in 2 cases, the
results were discordant. Therefore, when considering an abnormal PAT tracing as
indicative of mental stress-driven myocardial ischemia, concordance of the two methods
was 88%. This means that there was an 88% correlation between peripheral arterial
vasoconstriction and mental stress testing. Thus, the use of peripheral arterial tonometry
has the potential to facilitate both clinical testing and research during mental stress, which
is assumed to be directly associated with peripheral arterial vasoconstriction.3 5
Estimation of Central Aortic Pressure Waveform by Mathematical Transformation of
Radial Tonometry Pressure:
In the third study, researchers developed mathematical transfer functions that use
peripheral tonometry data to predict central aortic pressures and waveforms, which
convey important information about a person's health but can only be measured
invasively. Peripheral pressures can be measured noninvasively, and although they often
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differ substantially from central pressures, they may be mathematically transformed to
approximate the latter. By examining intersubject and intrasubject variability and the
validity of using a single averaged transformation (which enhances its applicability),
central aortic pressures were accurately estimated from radial tonometry with the use of a
generalized transfer function. The reconstructed waveform provided arterial compliance
estimates but underestimated the augmentation index because the latter requires greater
fidelity reproduction of the wave contour. More specifically, invasive central aortic
pressure by micromanometer and radial pressure by automated tonometry were measured
in 20 patients at steady state and during hemodynamic transients (Valsalva maneuver,
abdominal compression, nitroglycerin, or vena caval obstruction). For each patient,
transfer functions (TFs) between aortic and radial pressures were calculated by parametric
model and results averaged to yield individual TFs. A generalized TF was the average of
individual functions. TFs varied among patients, with coefficients of variation for peak
amplitude and frequency at peak amplitude of 24.9% and 16.9%, respectively.
Intrapatient TF variance with altered loading (>20% variation in peak amplitude) was
observed in 28.5% of patients. Despite this, the generalized TF estimated central arterial
pressures to <0.2±3.8 mm Hg error, arterial compliance to 6±7% accuracy, and
augmentation index to within -7% points (30±45% accuracy). Individual TFs were only
marginally superior to the generalized TF for reconstructing central pressures.3 6
4.6 Thermal-Based Assessment via Temperature
There are many limitations to the existing methods for identifying endothelial
dysfunction, some of which include operator-dependent variability, inconsistent
reproducibility, and complex analysis of data. A thermal based approach that can reduce
or eliminate these limitations will prove to be a more useful tool for assessing vascular
health.
4.6.1 Research at the University of Texas
In 2003 and 2004, researchers at the University of Texas were exploring a
temperature based technique for measuring endothelial dysfunction. This technique takes
advantage of the response of endothelial cells to changes in pressure. Pressure changes
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cause the cells to produce nitric oxide which in turn causes blood vessels to dilate. This
vasodilation can be induced by temporarily blocking blood flow and causing reactive
hyperemia - an increase in blood flow resulting from the restoration of temporarily
blocked flow. Valvano and his colleagues are developing a technique to measure
endothelial dysfunction by causing reactive hyperemia in the arm and measuring the
temperature variations of the hand region. They create reactive hyperemia by occluding
the arm by blood pressure cuff at about 200 mmHg for 5 minutes, and then suddenly
releasing the pressure. Using a computer-based data acquisition system, the temperature
variations of the distal palmer pad/middle finger, during the entire procedure are
continuously monitored.3 A sample of results is shown in Figure 4-7.
Figure 4-7: Valvano's preliminary results for predicting endothelial dysfunction using temperature
variations.
To analyze data and make it useful for assessing endothelial dysfunction,
Kharalkar and Valvano study the rate of temperature fall during occlusion and the rate of
temperature rise after release. Initial studies on normal subjects have indicated that the
rate of temperature increase is significantly higher than the rate of temperature
decrease. 3 8
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4.6.2 Naqvi, Shah, Kaul, and Naghavi Present Data for
Assessment via Temperature
A temperature based approach to assessing endothelial dysfunction is also
described in a PowerPoint presentation given by Principal Investigator, Tasneem Z
Naqvi, MD on December 16, 2003 at the University of California Los Angeles.39 Naqvi's
co-investors are P.K. Shah, MD, Sanjay Kaul, MD and the founder of a vascular health
company named Endothelix, Morteza Naghavi, MD.
The team describes the assessment of endothelial function by this novel
temperature-based method. Their hypothesis is that digital temperature changes in
response to hyperemia is a marker of endothelial function, and their overall aim is to
determine if digital temperature change in response to hyperemia correlates with brachial
artery reactivity as measured by ultrasound. The technique utilizes the change of
temperature as an indicator of change in flow, where the slope and pattern of temperature
rise at the finger tips after release of occlusion correlate with brachial vasoreactivity.
They claim that the benefits of this device are that it is cheap, can be self-administered,
and can be easily adapted into home-based blood pressure monitoring device.40
This team performed an experiment to monitor brachial artery flow-mediated
vasodilation, as depicted in Figure 4-8.
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Figure 4-8: Schematic diagram for the temperature-based test procedure 40
Sample results for endothelial function measured by digital thermal monitoring at the tip
of the index finger are shown in Figure 4-9.
Temperature Monitoring of Middle Fingertip Before
and After Releasing Blood Pressure Cuff
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Figure 4-9:Temperature monitoring results4
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The parameters that can be measured from the graph in Figure 4-9 are the rate of
temperature fall after the cuff is inflated, the rate of temperature rise after the cuff is
deflated, and the percent increase in temperature post hyperemia.
4.6.3 Thermal Method Is Used by Endothelix
Endothelix is a Delaware corporation based in Houston, Texas and was formed in
December 2003. The company is dedicated to promoting vascular endothelial health;
their products are intended to help practicing physicians to regularly monitor their
patient's endothelial function and use appropriate therapies for treatment of endothelial
dysfunction. On January 16, 2006, a press release stated that Endothelix received an
exclusive license from the University of Texas Health Science Center and the Texas
Heart Institute for the thermal detection of endothelial dysfunction. The technology
measures a marker of vascular endothelial dysfunction by monitoring temperature
changes at the fingertip. Dr. Morteza Naghavi, the founder of Endothelix, inventor of the
technology, and former director of the Vulnerable Plaque Research Center at the UT
Houston Health Science Center and the Texas Heart Institute, says "Endothelial function
monitoring can fill the gap between heart attack risk factor measurements, such as blood
tests, and advanced imaging technologies like heart scans." Dr. Michael Jamieson, who
sits on Endothelix's Advisory Board, says "An accurate, automated (operator-
independent), and inexpensive method of monitoring endothelial function for clinical
practice can make as great an impact on today's medicine as automated blood pressure
monitoring devices have done for blood pressure monitoring in the past decade."
Essentially, Endothelix is positioning itself as a leader in endothelial function
monitoring. 4 1
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5 A Novel Thermal-Based Approach:
Assessment via Temperature and Perfusion
5.1 The Advantage of Monitoring Perfusion
The existing thermal based approaches use changes in temperature during reactive
hyperemia as an indicator of the health of endothelial cells. The temperature at the finger
tips reflects changes in the level of blood perfusion to the fingers. In other words, the
source of these temperature changes is a change in the balance between heat loss to the
environment, heat gain from perfusion, and local tissue metabolism (which may not vary
much during the short occlusion). When blood flow to the arm is temporarily occluded,
the temperature of the tissue downstream of the occlusion decreases with time as the
warmer arterial blood coming from the body's core is removed from the overall tissue
heat balance. After occlusion, the blood is allowed to rush back into the arterial blood
vessels, leading to a rapid increase in measured tissue temperature. The more vasodilation
there is, the greater the perfusion following occlusion. Thus, a method to accurately
measure perfusion allows the quantification of reactive hyperemia, which can provide
valuable insight into the health of endothelial cells. In addition to looking at temperature
as an indicator of vascular health, this approach is also concerned with the source of the
temperature changes, which is perfusion.
5.2 Simple Thermal Analyses
To analyze this phenomenon of assessing vascular health using temperature and
perfusion measurements, two simple thermal models were employed. One model
describes the temperature profiles within unperfused tissue when a constant temperature
probe is placed in contact with the surface of the skin. The second model describes the
temperature profile for perfused tissue.
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5.2.1 Heated Disk In Contact with Skin
When the constant temperature electrode comes into contact with the skin, the
surface of the skin is assumed to be instantaneously set to the same temperature as the
probe. The underlying layers of tissue experience the temperature gradient and isotherms
shown in Figure 5-1.
ral . r__I
Figure 5-1: Heated disk at constant temperature, Ts, and the corresponding isothems in the
underlying skin tissue.
In this analysis the skin and underlying tissue is modeled as a semi-infinite solid
with heat diffusivity a=O.l mm2/s. Focusing on the local heating caused by the disk in
contact with the skin, Figure 5-2 depicts a schematic representation of this phenomenon.
In this figure, temperature, T, is graphed as a function of distance into the skin, x, at
different instances in time, t. Ti is the initial temperature of the skin; in other words, it is
the skin's temperature before the thermal probe comes into contact with it.
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TFigure 5-2: Temperature profile in semi-infinite solid
The governing equation for this model is the one-dimensional form of the heat diffusion
equation
aT a2T
at a (1)
The solution to this equation for the case at hand is given by42
T -T = erfc x (2)24~i (2)
T, - Ti 24at
Consider the case where the difference between skin temperature and initial temperature,
T-Ti, is within 10% of the difference between surface temperature and initial temperature,
Ts-Ti. For this case the equation reduces to
0.1 = erfc x(3)
2·fa
According to computation tables for the complementary error function, the argument of
this function equals 1.16 when the value of the function is 0.1009. Therefore, for the case
being considered,
1.16 = - (4)
which leads to the solution,
x(t) = 2.32,f-t (5)
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When x is plotted as a function of time, the following graph is achieved
Disiance vs. Time-forT-T = 10% (T-T)
Time (s)
Figure 5-3: Plot of distance underneath skin where the difference between temperature under skin
surface and initial temperature is within 10% of the difference between surface temperature and
initial temperature, as a function of time.
In the model and solutions obtained thus far the effect of perfusion has been
ignored. Due to this neglect of perfusion, the graph in Figure 5-3 never reaches a steady
state. Nevertheless, this model is suitable for estimating the temperature in the skin,
where there is relatively little blood perfusion. When looking at depths that involve the
tissue where there are physiologic levels of perfusion, this perfusion must be accounted
for.
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5.2.2 Accounting for Blood Perfusion
The bioheat transfer equation is used to describe the temperature field in a
continuous, homogenous, perfused tissue and is given by43
aT qr PbCb (Tm
a, aX+ am - _A - b Ta) = T (6)2 t km PmCm at
where a is tissue diffusivity, T is temperature, x is distance into the tissue, q is local tissue
metabolic heat generation, k is conductivity, p is density, c is heat capacity, and c is
blood perfusion. The subscript m refers to these parameters in the tissue while the
subscript b is used to identify properties of the blood. In order to reduce this equation into
a simple analytical form, the following assumptions are made:
· The density and heat capacity of blood is comparable to that of tissue. In
otherwords, PbCb ~ pmCm
* Metabolic heat generation, q,, is small and serves to establish the tissue baseline
temperature, T
* The probe operates under quasi-steady state conditions
Using these assumptions, the bioheat transfer equation reduces to
92 T 0= T - c(T-Ti) (7)
2 Ca
A solution to this differential equation can be obtained by noticing that equation 7
has the same form as the fm equation.44 Following a similar approach to that used to
solve the fin equation and applying the boundary conditions T=T, at x=O and T=Ti at x=L
(where L is the thickness of the tissue), yields the solution in equation 8.
T- T = sinh m(L - x) where m = (8)
T -T sinh(mL) (8)
The tissue diffusivity, a, is taken to be 0.1 mm2/s. To determine suitable values for
perfusion, the clinical perfusion units of mL/100g-min must be converted into local
perfusion with units of 1/s. The appropriate conversion factor is 1/6000 such that local
perfusion, w, is equal to (1/6000) x Clinical Perfusion. Typical values for clinical
perfusion range from 0-50 mL/100Og-min, thereby resulting in local perfusion values
ranging from 0-0.0083 s- .
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For the temperature profile where the difference between the temperature in the
tissue and the initial temperature of the tissue, T-Ti, is 10% of the difference between the
temperature at the surface of the skin and the initial temperature of the tissue, Ts-Ti, the
T-T
left-hand expression of equation 8 simply becomes T T = 0.1 . Solving for perfusion as
a function of the distance into the tissue where this temperature profile occurs yields
equation 9.
mL - sinh-' (0.1 sinh mL)
m
Figure 5-4 contains a graphical representation of equation 9 for different values of tissue
thicknesses, L.
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Figure 5-4: Perfusion as a function of the distance into the tissue where the difference between
temperature under skin surface and initial temperature is within 10% of the difference between
surface temperature and initial temperature, for different values of tissue thicknesses.
The chart in Figure 5-4 can be used to predict the thermal interrogation depth - that
is the depth into the tissue at which the probe is measuring and registering perfusion
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values. This distance will correspond with the location in the tissue where the difference
between tissue temperature and initial temperature, T-Ti, is within 10% of the difference
between surface temperature and initial temperature, Ts-Ti. The curve for a tissue
thickness of 75mm is very close to that for 100mm, and therefore it is not shown. For
tissue thicknesses greater than 100mm, the curves are essentially the same as that of
L= 00mm. For all thicknesses, the depth into the tissue where the temperature curve
settles within 10% is between 9mm and 16mm for clinical perfusion values between
50mL/00g-min and 12mL/100g-min, respectively. Essentially, the higher the perfusion
level, the smaller the depth of interrogated tissue.
5.3 Prototype Probe Design
The probe used for testing was a simple modification of an existing invasive
temperature probe that is currently used to measure blood perfusion in the brain during
and after neurosurgery. The existing probe and its accompanying modification are shown
in Figure 5-5.
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Figure 5-5: Thermal diffusion probe4 5 with modified distal end.
The distal end of the probe has two exposed thermistors. The surface of the thermistor is
controlled to a small increment (-2 °C) above the tissue baseline temperature. The power
dissipated in the thermistor provides a measure of the ability of the tissue to carry heat by
both thermal conduction within the tissue and by thermal convection due to tissue blood
flow. The passive, proximal thermistor is used to monitor and compensate for temporal
tissue baseline temperature changes.45
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This modification was created by removing approximately 0.5 inch of catheter to
expose the two thermistors. The thermal probe with exposed thermistors was connected
to the perfusion monitor via an umbilical cord.
5.4 Preliminary Testing
The umbilical cord of the probe is inserted into the multi-pin connector on the left-
hand side of the perfusion monitor shown in Figure 5-6.
Figure 5-6: Perfusion Monitor 45
This probe was tested on three subjects. The two exposed thermistors of the temperature
probe, wetted with glycerol to increase thermal communication, were placed on the
subject's thumb pad and covered with an adhesive-based insulating patch. The monitor is
designed to wait for temperature stability of approximately 0.020°C over a 30 second
time period. Tissue thermal conductivity was computed from the initial power vs. time
record and displayed on the screen; perfused skin thermal conductivity values ranged
from 2.8 to 3.5 mW/°C-cm. Thereafter, power and temperature data was collected at a
sampling rate of 1 Hz. Perfusion was computed from the solution of a coupled probe-
tissue thermal model.4 6
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5.5 Results and Discussion
Thermal stabilization took longer than desired due to the tight stability settings
appropriate for an implanted neurological perfusion probe. Following thermal
stabilization, the tissue thermal conductivity was calculated from power time
measurements; and as a final step, the value of perfusion was extracted. The calculated
perfusion values of all three subjects tested was zero. Consequently, of the three subjects
tested, there was no usable data for evaluation and no time to collect additional data. The
calibration parameters of the sensors also may have been out of specification.
Nonetheless, an interesting phenomenon was discovered in the process. Whenever
pressure was applied to the probe, the machine output clinical perfusion values ranging
from 0-48mL/l00g-min. This could suggest poor thermal coupling between the probe and
tissue.
Despite the fact that the prototype system used had an unknown glitch, past data
corroborates the phenomenon that perfusion measurements can be used to assess
endothelial health. This data is presented in Figures 5-7 to 5-10 and used with permission
from Dr. Bowman.
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Figure 5-7 shows the results of continuous perfusion measurements (including
vasomotor activity and reactive hyperemia) during repeated occlusion of a rabbit
epigastric flap. The expected vasomotor activity is witnessed throughout the course of the
experiment. Although this activity looks like noise, it in fact reflects the arteries
undergoing continual rapid contraction and dilation as part of the normal regulation of
flow; endothelial cells regulate this vasomotor activity. After release of the arterial
occlusion, the reactive hyperemia results in a perfusion measurement that is above the
baseline measurement. For successive arterial occlusions followed by release, the
resulting perfusion value is considerably increased as the reactive hyperemia is not
allowed to return to baseline before the next occlusion takes place.
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Figure 5-7: Invasive thermal diffusion probe measurements in a rabbit epigastric flap subjected to
repeated arterial occlusions. Note vasomotor response and reactive hyperemia.
In Figure 5-8, the results of successive application of an arm tourniquet to a 54-
year-old male who had never been diagnosed any form of vascular disease is shown. This
method of arterial occlusion was followed by release 300s later with both temperature
and perfusion recorded. Similar reactive hyperemia and vasomotor response results were
obtained. Furthermore, notice that more information about vasomotor activity is obtained
from the perfusion graph as compared with that of the temperature graph. This graph
serves as supporting evidence that measuring perfusion along with temperature can
provide more insight into a person's vascular health when compared with measuring
temperature alone.
Figure 5-8: Non-invasive thermal diffusion probe measurements of blood flow in a finger of a normal
54-year-old male volunteer in response to successive applications of arm tourniquet. Note vasomotor
response and hyperemia.
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In Figure 5-9 the results for a 21-year-old female who had never been diagnosed
with any type of vascular disease is shown. In comparison to the male in Figure 5-8, this
female volunteer returns to her baseline perfusion and temperature more readily. Once
again the perfusion plot conveys more information about vasomotor activity than the
temperature plot does. Also, for some reason, this female experiences two distinct
perfusion peaks for every trial of occlusion followed by immediate release. This detail
can not be easily discerned from the temperature plot.
Figure 5-9: Non-invasive thermal diffusion probe measurements of perfusion in a finger of a normal
21-year-old female volunteer in response to successive applications of arm tourniquet. Note
vasomotor response and reactive hyperemia.
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Figure 5-10 shows the results for a 60-year-old male who was being treated for
hypertension. The most outstanding difference between these results and those shown in
the other volunteers is the lack of vasomotor activity. Additionally, after occlusion
followed by immediate release, the reactive hyperemia peak is not as pronounced.
Figure 5-10: Non-invasive thermal diffusion probe measurements of perfusion in thumb pad of a 60-
year-old male volunteer being treated for hypertension. Note lack of vasomotor activity.
Based on the observations in Figures 5-7 to 5-10, there appears to be a highly
promising application for identifying endothelial dysfunction using perfusion
measurements. The use of perfusion along with temperature also has advantages over
using temperature alone. Furthermore, this approach reduces some of the problems
associated with non-thermal methods. Once standard set-up procedures are performed,
the results are not operator dependent. Additionally the results can be reproduced with a
fair amount of consistency, as shown in the successive measurements for occlusion
followed by release for each test subject. Finally, a computer program can be written to
automatically analyze resulting data. Maybe the program can analyze peaks, characterize
vasomotor activity, and calculate slopes for the decreasing perfusion after occlusion and
release.
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6 Conclusion and Recommendations
There are many methods available for measuring and assessing vascular health.
Each method has its own unique limitations. A thermal based approach has the potential
to eliminate some of the limitations seen with other measurement techniques. Perfusion
and temperature serve as promising parameters for identifying endothelial dysfunction.
The method of using a thermal diffusion probe could be standardized to test the vascular
health status of individuals. An immediate next step is to debug the perfusion technique
such that meaningful results could be obtained from the prototype probe. One might also
want to consider using a blood pressure cuff to apply a constant pressure on the probe as
data is being recorded.
The data returned from the perfusion monitor should be analyzed to extract
important measurable data such as peaks, slopes, and vasomotor activity. A computer
program could be written for these peak analysis, vasomotor activity characterizations,
and slope calculations. This type of data analysis program could then be incorporated in
the perfusion monitor to avoid the limitations due to variations in operator-dependent
data analysis.
Other additional work would include increasing the accuracy and reproducibility
of data collection and identifying body sites that are most revealing of general vascular
health.
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